Literature DB >> 11743717

Kinetic and mechanistic analysis of the RNA polymerase II transcrption reaction at the human interleukin-2 promoter.

H A Ferguson1, J F Kugel, J A Goodrich.   

Abstract

Interleukin-2 (IL-2) is a cytokine critical for the proper stimulation of T-cells during the mammalian immune response. Shortly after T-cell stimulation, transcription of the IL-2 gene is upregulated. Here, we studied the kinetic mechanism of basal transcription at the IL-2 promoter using a human in vitro RNA polymerase II transcription system. We experimentally divided the transcription reaction into discrete steps, including preinitiation complex formation, initiation, escape commitment, and promoter escape. Using pre-steady state approaches, we measured the rate at which each of these steps occurs. We found that the rate of functional preinitiation complex formation limits the overall rate of transcription at the IL-2 promoter under the conditions described here. Furthermore, we found that the recruitment of TFIIF and RNA polymerase II to a TFIID/TFIIA/TFIIB/promoter complex dictates the rate of preinitiation complex formation. The rate of synthesis of 28 nt RNA from preinitiation complexes was rapid compared to the rate of preinitiation complex formation. Moreover, we found that the synthesis of a four nucleotide RNA was necessary and sufficient to rapidly complete the escape commitment step of transcription at the IL-2 promoter. Comparative experiments with the adenovirus major late promoter revealed that, while the overall mechanism of transcription is the same at the two promoters, promoter sequence and/or architecture dictate the rate of promoter escape. We present a kinetic model for a single round of basal transcription at the IL-2 promoter that provides insight into mechanisms by which the IL-2 gene is transcriptionally regulated. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11743717     DOI: 10.1006/jmbi.2000.5215

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  7 in total

1.  TFIIH operates through an expanded proximal promoter to fine-tune c-myc expression.

Authors:  Achim Weber; Juhong Liu; Irene Collins; David Levens
Journal:  Mol Cell Biol       Date:  2005-01       Impact factor: 4.272

2.  Characterization of the sequence and architectural constraints of the regulatory and core regions of the human interleukin-2 promoter.

Authors:  Jessica R Weaver; Kristi Good; Ryan D Walters; Jennifer F Kugel; James A Goodrich
Journal:  Mol Immunol       Date:  2007-03-06       Impact factor: 4.407

3.  The C-terminal region of human NFATc2 binds cJun to synergistically activate interleukin-2 transcription.

Authors:  Tuan N Nguyen; Loree J Kim; Ryan D Walters; Linda F Drullinger; Tricia N Lively; Jennifer F Kugel; James A Goodrich
Journal:  Mol Immunol       Date:  2010-06-16       Impact factor: 4.407

4.  A TATA binding protein regulatory network that governs transcription complex assembly.

Authors:  Kathryn L Huisinga; B Franklin Pugh
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

5.  A local regulatory T cell feedback circuit maintains immune homeostasis by pruning self-activated T cells.

Authors:  Harikesh S Wong; Kyemyung Park; Anita Gola; Antonio P Baptista; Christine H Miller; Deeksha Deep; Meng Lou; Lisa F Boyd; Alexander Y Rudensky; Peter A Savage; Grégoire Altan-Bonnet; John S Tsang; Ronald N Germain
Journal:  Cell       Date:  2021-06-21       Impact factor: 66.850

6.  Single molecule microscopy reveals mechanistic insight into RNA polymerase II preinitiation complex assembly and transcriptional activity.

Authors:  Abigail E Horn; Jennifer F Kugel; James A Goodrich
Journal:  Nucleic Acids Res       Date:  2016-04-25       Impact factor: 16.971

7.  NFATc2 recruits cJun homodimers to an NFAT site to synergistically activate interleukin-2 transcription.

Authors:  Ryan D Walters; Linda F Drullinger; Jennifer F Kugel; James A Goodrich
Journal:  Mol Immunol       Date:  2013-05-09       Impact factor: 4.407

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.